GLORIA MELANIE (Chief Operating Officer) sold 1.9% of their position (3.24K shares) of IMMUNOVANT, INC. on the open market
Open‑market sale worth $90.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 2/27/2026ACC: 0001764013-26-000013
Officer· Chief Operating Officer
Since Feb 2026
-3.24K
Net shares
Net seller
$90.2K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
3.24K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−1.44K
Price / share
$26.98
Trade value
$38.77K
% of position
0.8%
2/25/2026
173.51K→172.07K
Common Stock
Direct
Shares
−859.00
Price / share
$28.16
Trade value
$24.19K
% of position
0.5%
2/25/2026
172.07K→171.22K
Common Stock
Direct
Shares
−942.00
Price / share
$28.90
Trade value
$27.22K
% of position
0.6%
2/25/2026
171.22K→170.27K
Total
Net shares
−3.24K
Net value
-$90.18K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/25/2026 | S · Sale | −1.44K | $26.98 | $38.77K | 0.8% | 173.51K | 172.07K |
| Common Stock Direct | 2/25/2026 | S · Sale | −859.00 | $28.16 | $24.19K | 0.5% | 172.07K | 171.22K |
| Common Stock Direct | 2/25/2026 | S · Sale | −942.00 | $28.90 | $27.22K | 0.6% | 171.22K | 170.27K |
| Total | −3.24K | -$90.18K | ||||||
Derivative Transactions0
No derivative transactions reported